These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6642133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Etiology of bromate-induced cancer and possible modes of action-studies in Japan.
    Umemura T, Kurokawa Y.
    Toxicology; 2006 Apr 17; 221(2-3):154-7. PubMed ID: 16473452
    [Abstract] [Full Text] [Related]

  • 4. [Carcinogenicity of potassium bromate in F-344 rats].
    Ohno Y, Onodera H, Takamura N, Imazawa T, Maekawa A, Kurokawa Y.
    Eisei Shikenjo Hokoku; 1982 Apr 17; (100):93-100. PubMed ID: 7183412
    [No Abstract] [Full Text] [Related]

  • 5. Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold.
    Wei M, Hamoud AS, Yamaguchi T, Kakehashi A, Morimura K, Doi K, Kushida M, Kitano M, Wanibuchi H, Fukushima S.
    Toxicol Pathol; 2009 Dec 17; 37(7):983-91. PubMed ID: 19833912
    [Abstract] [Full Text] [Related]

  • 6. Carcinogenicity of potassium bromate administered orally to F344 rats.
    Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T, Odashima S.
    J Natl Cancer Inst; 1983 Nov 17; 71(5):965-72. PubMed ID: 6580498
    [Abstract] [Full Text] [Related]

  • 7. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration.
    Kurokawa Y, Aoki S, Matsushima Y, Takamura N, Imazawa T, Hayashi Y.
    J Natl Cancer Inst; 1986 Oct 17; 77(4):977-82. PubMed ID: 3463824
    [Abstract] [Full Text] [Related]

  • 8. Induction of renal cell tumors in F-344 rats by oral administration of potassium bromate, a food additive.
    Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T.
    Gan; 1982 Apr 17; 73(2):335-8. PubMed ID: 7117760
    [No Abstract] [Full Text] [Related]

  • 9. Potassium bromate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1986 Apr 17; 40():207-20. PubMed ID: 3473002
    [No Abstract] [Full Text] [Related]

  • 10. Relationship between the duration of treatment and the incidence of renal cell tumors in male F344 rats administered potassium bromate.
    Kurokawa Y, Matsushima Y, Takamura N, Imazawa T, Hayashi Y.
    Jpn J Cancer Res; 1987 Apr 17; 78(4):358-64. PubMed ID: 3108216
    [Abstract] [Full Text] [Related]

  • 11. DL-Serine: promoting activity on renal tumorigenesis by N-ethyl-N-hydroxyethylnitrosamine in rats.
    Hiasa Y, Enoki N, Kitahori Y, Konishi N, Shimoyama T.
    J Natl Cancer Inst; 1984 Jul 17; 73(1):297-9. PubMed ID: 6429402
    [Abstract] [Full Text] [Related]

  • 12. Basic lead acetate: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Hiasa Y, Ohshima M, Kitahori Y, Fujita T, Yuasa T, Miyashiro A.
    J Natl Cancer Inst; 1983 Apr 17; 70(4):761-5. PubMed ID: 6572762
    [Abstract] [Full Text] [Related]

  • 13. Trisodium nitrilotriacetate monohydrate: promoting effects on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Hiasa Y, Kitahori Y, Konishi N, Enoki N, Shimoyama T, Miyashiro A.
    J Natl Cancer Inst; 1984 Feb 17; 72(2):483-9. PubMed ID: 6582331
    [Abstract] [Full Text] [Related]

  • 14. beta-Cyclodextrin: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Hiasa Y, Ohshima M, Kitahori Y, Konishi N, Fujita T, Yuasa T.
    J Natl Cancer Inst; 1982 Oct 17; 69(4):963-7. PubMed ID: 6956770
    [Abstract] [Full Text] [Related]

  • 15. Strain and sex differences in kidney carcinogenesis in rats treated with N-ethyl-N-hydroxyethylnitrosamine and uracil.
    Yamada Y, Takashi M, Sakata T, Nakano Y, Takagi Y, Hibi H, Miyake K.
    Hinyokika Kiyo; 1995 Oct 17; 41(10):781-7. PubMed ID: 8533674
    [Abstract] [Full Text] [Related]

  • 16. A possible role for oxidative stress in potassium bromate (KBrO3) carcinogenesis.
    Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y.
    Carcinogenesis; 1995 Mar 17; 16(3):593-7. PubMed ID: 7697818
    [Abstract] [Full Text] [Related]

  • 17. Sequential observations on the appearance of neoplastic lesions in the liver and kidney after treatment with N-ethyl-N-hydroxyethylnitrosamine followed by partial hepatectomy and unilateral nephrectomy.
    Tsuda H, Sakata T, Tamano S, Okumura M, Ito N.
    Carcinogenesis; 1983 Mar 17; 4(5):523-8. PubMed ID: 6850982
    [Abstract] [Full Text] [Related]

  • 18. Effect of phenobarbital, polychlorinated biphenyl and sodium saccharin on hepatic and renal carcinogenesis in unilaterally nephrectomized rats given N-ethyl-N-hydroxyethylnitrosamine orally.
    Hirose M, Shirai T, Tsuda H, Fukushima S, Ogiso T, Ito N.
    Carcinogenesis; 1981 Mar 17; 2(12):1299-302. PubMed ID: 6799217
    [Abstract] [Full Text] [Related]

  • 19. [Eosinophilic bodies in the proximal renal tubules of rats given potassium bromate].
    Onodera H, Tanigawa H, Matsushima Y, Maekawa A, Kurokawa Y, Hayashi Y.
    Eisei Shikenjo Hokoku; 1985 Mar 17; (103):15-20. PubMed ID: 2420396
    [No Abstract] [Full Text] [Related]

  • 20. Histopathological studies on renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Hiasa Y, Ohshima M, Iwata C, Tanikake T.
    Gan; 1979 Dec 17; 70(6):817-20. PubMed ID: 231537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.